Welcome to Santhera!

We thank you for your interest in our company. To find information about any of the following areas or get in touch with our organization, please use the links or refer to contact information below.

General inquiries

Product availability of Raxone varies by the country from which the order is being placed. Here you can find country-specific information.

In the media section you find press releases and journalist contacts.

The investor toolbox features information for investors and analysts including financial reports, share information and investor contacts.

Santhera Pharmaceuticals is a dynamic and international employer in medical science and is always looking for talented colleagues. Please review our job openings and send your CV and motivation letter by email to: career@santhera.com.

On this page, further down, you find the relevant contact details in case of a need to report safety information.

Santhera Subsidiaries

Santhera Pharmaceuticals Holding AG (Headquarters)
Santhera Pharmaceuticals (Schweiz) AG
Hohenrainstrasse 24
4133 Pratteln
Phone +41 61 906 89 50
Fax +41 61 906 89 51

How to find Headquarters Pratteln

Santhera (Germany) GmbH
Central Europe cluster (Germany, Austria, Switzerland)
Arnulfstrasse 199
80634 Munich
Phone +49 89 189 85 100
Fax +49 89 189 85 10

Access Santhera Munich

Santhera (Netherland) B.V.
Western Europe cluster (France, Spain, The Netherlands, Belgium, Portugal, Luxemburg)
Weverstede 27A
3431 JS Nieuwegein
The Netherlands
Office phone +31 30 820 1029

Santhera (Italy) S.r.l.
Via Rosellini 12
20124 Milano
Phone +39 02 69 311 926
Fax +39 02 60 73 6164

Santhera (UK) Ltd
Northern Europe cluster (Denmark, Norway, Iceland, Sweden, Finland, UK, Ireland)
26-28 Hammersmith Grove
2nd Floor
London W6 7HA
United Kingdom
Phone +44 20 3434 5740

Santhera Pharmaceuticals (USA), Inc.
25 Corporate Drive, Suite 250
Burlington, MA 01803
Phone +1 781 365 0301
Fax +1 781 365 0230
For medical inquiries regarding idebenone or Santhera’s pipeline products, please call: +1 800 887 6915

All other countries
For all other countries please contact headquarters at phone +41 61 906 89 50 or office@santhera.com.

Reporting of safety information

Reporting suspected adverse reactions after authorization of the medicinal product is important as this will allow quick identification of new safety information. Please report any suspected adverse reactions to Raxone® (idebenone) by telephone or email to:

Phone: +44 1423 850 750
Email: santhera@EU.propharmagroup.com

For products in development please contact:

EU qualified person for pharmacovigilance (EU QP PV)
Phone: +47 48 18 57 88
Email : peter.psarologos@ubc.com

Deputy EU QP PV
Phone : +41 79 315 1086
Email: omer.demol@santhera.com